Tuberculosis associated thrombocytopenic purpura: effectiveness of antituberculous therapy

  • Raphael Borie | raphael.borie@bch.aphp.fr Department of Pneumology A, Hospital Bichat. Assistance Publique – Hôpitaux de Paris,, France.
  • Claire Fieschi Department of Clinical Immunology, Hospital St Louis. Assistance Publique – Hôpitaux de Paris, Paris, France, France.
  • Eric Oksenhendler Department of Clinical Immunology, Hospital St Louis. Assistance Publique – Hôpitaux de Paris, Paris, France, France.
  • Lionel Galicier Department of Clinical Immunology, Hospital St Louis. Assistance Publique – Hôpitaux de Paris, Paris, France, France.

Abstract

Association of immune thrombocytopenic purpura and tuberculosis is a rare condition. In 5 patients presenting with this association, anti-tuberculous therapy was effective on both tuberculosis and thrombocytopenia suggesting a causal relationship between tuberculosis and immune thrombocytopenic purpura

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biography

Raphael Borie, Department of Pneumology A, Hospital Bichat. Assistance Publique – Hôpitaux de Paris,
oa gif
Published
2009-03-06
Info
Issue
Section
Original Articles
Keywords:
immune thrombocytopenic purpura, immune, peripheral, thrombocytopenia
Statistics
  • Abstract views: 888

  • PDF: 441
  • HTML: 2088
How to Cite
Borie, R., Fieschi, C., Oksenhendler, E., & Galicier, L. (2009). Tuberculosis associated thrombocytopenic purpura: effectiveness of antituberculous therapy. Hematology Reports, 1(1), e3. https://doi.org/10.4081/hr.2009.e3